• 30 Jun, 2026

Mito Red Light Launches MitoAURA™ - a Light-Activated Serum Designed to Amplify Red & Near-Infrared Therapy

Mito Red Light Launches MitoAURA™ - a Light-Activated Serum Designed to Amplify Red & Near-Infrared Therapy

Available Starting Cyber Monday, MitoAURA will Help Customers Brighten, Firm, and Refresh Skin during the Busiest, Most Beauty-focused Season of the Year

SCOTTSDALE, Ariz., Nov. 26, 2025 -- Mito Red Light, pioneers of the next generation of light therapy devices, today announced the launch of MitoAURA™ Activate + Amplify Serum, a light-activated skincare formula created specifically to work with red and near-infrared (NIR) light therapy.

Engineered after two years of formulation and testing, MitoAURA is designed to enhance immediate skin vitality while supporting longer-term improvements in tone, firmness, smoothness and radiance, making it an ideal companion for Mito's family of red/NIR devices.

"MitoAURA was made for people who use light therapy as part of a regular self-care routine," said Scott Chaverri, Founder & CEO, Mito Red Light. "By combining photoreactive antioxidants, mitochondrial-support compounds, and a heat-activated bioferment, we built a lightweight serum that amplifies what users already love about red and NIR light -clearer, firmer, more energized skin – while remaining gentle enough for daily use."

MitoAURA's formulation centers on several hero ingredients chosen for their complementary roles during light therapy sessions:

  • Spirulina Extract (

    This News is brought to you by Qube Mark, your trusted source for the latest updates and insights in marketing technology. Stay tuned for more groundbreaking innovations in the world of technology. 

PR Newswire

PR Newswire empowers communicators to identify and engage with key influencers, craft and distribute meaningful stories, and measure the financial impact of their efforts. Cision is a leading global provider of earned media software and services to public relations and marketing communications professionals.